<mark id="kgada"><ruby id="kgada"><legend id="kgada"></legend></ruby></mark>

      <kbd id="kgada"></kbd>

    1. <wbr id="kgada"><noscript id="kgada"><output id="kgada"></output></noscript></wbr>
    2. <wbr id="kgada"><noscript id="kgada"><output id="kgada"></output></noscript></wbr> <mark id="kgada"></mark>

      1. <bdo id="kgada"><delect id="kgada"><legend id="kgada"></legend></delect></bdo>
        <i id="kgada"></i>

          Profile Core value Main business Legitimacy Social Responsibility
            Patents Research Direction Technology Strength
          API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
          Production management QC Quality System branch factory




          Products Center
        Paclitaxel (Semi-synthetic)
        Paclitaxel (Natural)
        Docetaxel Anhydrous
        Docetaxel Trihydrate
        Irinotecan HCl Trihydrate 99.5%
        Etoposide USP31
        Palonosetron Hydrochloride
          N-1 stage of Paclitaxel and Docetaxel
          Main Intermediates
        10-Deacetylbaccatin III
        Baccatin III
          Side chain for Paclixel semi-Synthetic
        (4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
          Side chain of Docetaxel
        (4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
          Side chain for Paclitaxel and Docetaxel
        Ethyl (2R,3S)-3-Phenylisoserine Ester
        Your location:Home>>About us>>Social Responsibility

        Jinhe is fully aware that the development of enterprises is not only trying to obtain more economic benefits, but also trying to make more contribution to society, being an "enterprise citizen” beneficial to society.
        Jinhe has always been conscientious of its production impact on environment, by actively controlling the emission of pollutants and heavily investing in the treatment of the pollutions. For many years, Jinhe has passed all inspection and assessment by State Environment Inspection Service.

        Jinhe focuses on the conservation of resources. Based on our own research results, Jinhe made in-depth study on the comprehensive utilization of Taxus, turning waste into useful, and greatly improved the comprehensive utilization efficiency of endangered species “Taxus”.

        Jinhe pays high attention on production cost control of anti-cancer drugs raw materials, and is committed to provide customers with low-cost raw materials of anticancer drug, thereby reducing the cost of anti-cancer drug products, so that more cancer patients can afford the expensive anticancer drug products, bringing more benefit to cancer patients.

        CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
        HOME About us Products R & D Production and QA Contact us CHINESE